In July 2024, the USFDA inspected the said facility with Zero Form – 483 observations and No Action Indicated (NAI) designation.
Piramal Pharma stock in focus after EIR from USFDA for Ahmedabad facility
view original post
In July 2024, the USFDA inspected the said facility with Zero Form – 483 observations and No Action Indicated (NAI) designation.